[go: up one dir, main page]

NO325077B1 - Anvendelse av S-metyl-dihydro-ziprasidon for fremstilling av et farmasoytisk preparat og en farmasoytisk blanding. - Google Patents

Anvendelse av S-metyl-dihydro-ziprasidon for fremstilling av et farmasoytisk preparat og en farmasoytisk blanding. Download PDF

Info

Publication number
NO325077B1
NO325077B1 NO20025760A NO20025760A NO325077B1 NO 325077 B1 NO325077 B1 NO 325077B1 NO 20025760 A NO20025760 A NO 20025760A NO 20025760 A NO20025760 A NO 20025760A NO 325077 B1 NO325077 B1 NO 325077B1
Authority
NO
Norway
Prior art keywords
disorder
condition
treated
use according
disorders
Prior art date
Application number
NO20025760A
Other languages
English (en)
Norwegian (no)
Other versions
NO20025760L (no
NO20025760D0 (no
Inventor
Teresa Annette Smolarek
Chandra Aggarwal Prakash
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26903852&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO325077(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20025760D0 publication Critical patent/NO20025760D0/no
Publication of NO20025760L publication Critical patent/NO20025760L/no
Publication of NO325077B1 publication Critical patent/NO325077B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20025760A 2000-06-02 2002-11-29 Anvendelse av S-metyl-dihydro-ziprasidon for fremstilling av et farmasoytisk preparat og en farmasoytisk blanding. NO325077B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20913600P 2000-06-02 2000-06-02
US21217200P 2000-06-16 2000-06-16
PCT/IB2001/000933 WO2001091756A2 (en) 2000-06-02 2001-05-28 S-methyl-dihydro-ziprasidone for treatment of psychiatric and ocular disorders

Publications (3)

Publication Number Publication Date
NO20025760D0 NO20025760D0 (no) 2002-11-29
NO20025760L NO20025760L (no) 2003-01-15
NO325077B1 true NO325077B1 (no) 2008-01-28

Family

ID=26903852

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025760A NO325077B1 (no) 2000-06-02 2002-11-29 Anvendelse av S-metyl-dihydro-ziprasidon for fremstilling av et farmasoytisk preparat og en farmasoytisk blanding.

Country Status (44)

Country Link
US (1) US20060287336A1 (es)
EP (3) EP1698338B1 (es)
JP (2) JP2003534381A (es)
KR (1) KR20030007824A (es)
CN (1) CN1431901A (es)
AP (2) AP1831A (es)
AR (1) AR028937A1 (es)
AT (3) ATE391507T1 (es)
AU (1) AU2001258690A1 (es)
BG (1) BG107267A (es)
BR (1) BR0111271A (es)
CA (1) CA2410618A1 (es)
CY (1) CY1105992T1 (es)
CZ (1) CZ20023860A3 (es)
DE (3) DE60133596D1 (es)
DK (1) DK1468686T3 (es)
DO (1) DOP2001000181A (es)
EA (1) EA007068B1 (es)
EC (1) ECSP024369A (es)
EE (1) EE200200670A (es)
ES (1) ES2277170T3 (es)
GE (1) GEP20053512B (es)
HN (1) HN2001000119A (es)
HR (1) HRP20020953A2 (es)
HU (1) HUP0301747A2 (es)
IL (2) IL152782A0 (es)
IS (1) IS6619A (es)
MA (1) MA26908A1 (es)
MX (1) MXPA02011862A (es)
NO (1) NO325077B1 (es)
NZ (1) NZ551012A (es)
OA (1) OA12267A (es)
PA (1) PA8518301A1 (es)
PE (1) PE20011329A1 (es)
PL (1) PL365576A1 (es)
PT (2) PT1468686E (es)
SI (1) SI1468686T1 (es)
SK (1) SK16622002A3 (es)
SV (1) SV2002000473A (es)
UA (1) UA79425C2 (es)
UY (1) UY26742A1 (es)
WO (1) WO2001091756A2 (es)
YU (1) YU90702A (es)
ZA (1) ZA200209665B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7419493B2 (en) 2002-12-13 2008-09-02 Regents Of The University Of Minnesota Scleral depressor
WO2005040160A2 (en) 2003-10-24 2005-05-06 Teva Pharmaceutical Industries Ltd. Processes for preparation of ziprasidone
ES2250001B1 (es) * 2004-09-29 2007-06-01 Medichem, S.A. Proceso para la purificacion de ziprasidona.
JP2012174228A (ja) * 2011-02-24 2012-09-10 Kyocera Corp プログラム保護装置および通信装置
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
US9981041B2 (en) * 2016-08-23 2018-05-29 Ira Jason Salzman Ophthalmic lubricating spray

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ508303A (en) * 1996-05-07 2001-07-27 Pfizer Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2(1H)-indol-2-one (ziprasidone) useful as a dopamine D2 antagonist
TW491847B (en) * 1996-05-07 2002-06-21 Pfizer Mesylate dihydrate salts of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one
DK0985414T3 (da) * 1998-05-26 2003-12-29 Pfizer Prod Inc Lægemiddel til behandling af glaukome og iskæmisk retinopati
CA2363942A1 (en) * 1999-04-06 2000-10-12 Sepracor Inc. Methods and compositions for the treatment of psychotic and related disorders using ziprasidone metabolites

Also Published As

Publication number Publication date
BG107267A (bg) 2003-06-30
MXPA02011862A (es) 2003-04-10
CY1105992T1 (el) 2011-04-06
EP1698338B1 (en) 2008-04-09
WO2001091756A3 (en) 2002-09-26
SV2002000473A (es) 2002-10-24
CA2410618A1 (en) 2001-12-06
IL152782A0 (en) 2003-06-24
PT1698338E (pt) 2008-06-03
NZ551012A (en) 2008-04-30
UA79425C2 (en) 2007-06-25
PL365576A1 (en) 2005-01-10
NO20025760L (no) 2003-01-15
DOP2001000181A (es) 2002-04-15
PE20011329A1 (es) 2002-01-15
DE60124791T2 (de) 2007-09-13
ATE391507T1 (de) 2008-04-15
ES2277170T3 (es) 2007-07-01
YU90702A (sh) 2005-11-28
EP1286672B1 (en) 2006-10-25
WO2001091756A2 (en) 2001-12-06
AR028937A1 (es) 2003-05-28
SI1468686T1 (sl) 2007-04-30
EP1468686B1 (en) 2006-11-22
AP1747A (en) 2007-05-31
AU2001258690A1 (en) 2001-12-11
SK16622002A3 (sk) 2004-07-07
GEP20053512B (en) 2005-05-10
EE200200670A (et) 2004-08-16
ZA200209665B (en) 2003-11-28
EP1698338A2 (en) 2006-09-06
DE60124791D1 (de) 2007-01-04
PT1468686E (pt) 2007-01-31
EP1468686A2 (en) 2004-10-20
MA26908A1 (fr) 2004-12-20
EA007068B1 (ru) 2006-06-30
PA8518301A1 (es) 2002-09-17
KR20030007824A (ko) 2003-01-23
UY26742A1 (es) 2001-12-28
JP2008056700A (ja) 2008-03-13
US20060287336A1 (en) 2006-12-21
CZ20023860A3 (cs) 2004-01-14
BR0111271A (pt) 2003-06-10
EP1468686A3 (en) 2004-12-01
NO20025760D0 (no) 2002-11-29
AP1831A (en) 2008-02-26
HN2001000119A (es) 2001-09-11
EA200201168A1 (ru) 2003-06-26
HUP0301747A2 (hu) 2003-09-29
EP1286672A2 (en) 2003-03-05
IS6619A (is) 2002-11-14
JP2003534381A (ja) 2003-11-18
EP1698338A3 (en) 2006-09-20
DE60124093D1 (de) 2006-12-07
ATE345818T1 (de) 2006-12-15
ATE343387T1 (de) 2006-11-15
HRP20020953A2 (en) 2005-02-28
ECSP024369A (es) 2003-02-06
DK1468686T3 (da) 2007-03-12
DE60133596D1 (de) 2008-05-21
OA12267A (en) 2004-01-20
AP2005003272A0 (en) 2005-03-31
IL152782A (en) 2007-10-31
CN1431901A (zh) 2003-07-23

Similar Documents

Publication Publication Date Title
EP2621916B1 (en) Benzazole derivatives as histamine h4 receptor ligands
NO325077B1 (no) Anvendelse av S-metyl-dihydro-ziprasidon for fremstilling av et farmasoytisk preparat og en farmasoytisk blanding.
US8859590B2 (en) Inhibitors of BACE1 and methods for treating Alzheimer's disease
US7772258B2 (en) Agent for treatment of allergic eye disease
TWI572603B (zh) １，４－苯並硫氮呯－１－氧化物衍生物之光學異構物及使用該等之醫藥組成物
US20250090491A1 (en) Antiviral 1,3-di-oxo-indene compounds
WO2020206109A1 (en) Remodilins for airway remodeling and organ fibrosis
NO179519B (no) Analogifremgangsmåte for fremstilling av 3-(1,2-benzisoksazol-3-yl)-4-pyridinaminer og derivater derav
CN114685519B (zh) 一类吡喃并咔唑生物碱衍生物及其治疗阿尔茨海默症的用途
JPWO1996000213A1 (ja) ピリジン誘導体
WO2019210880A1 (zh) 双并环脲类核衣壳抑制剂及其药物用途
CN108484591B (zh) 用于治疗阿尔茨海默症的化合物及其应用
US20220227709A1 (en) Compositions and methods for treating schistosoma infections
HK1053615A (en) S-methyl-dihydro-ziprasidone for treatment of psychiatric and ocular disorders
AU2007202939A1 (en) S-methyl-dihydro-ziprasidone for treatment of psychiatric and ocular disorders
JP3113447B2 (ja) アミノカルボン酸誘導体、その製造方法および用途
JPH11503132A (ja) 新規の複素環化合物
JP2004292366A (ja) １，２−ジオキサン化合物